Andrews Patricia S insider trades
Andrews Patricia S has filed 9 Form 4s with the SEC that we hold, for Crescent Biopharma, INC. (GLYC) (Director), Oncolytics Biotech INC (ONCY) (Director) and Geron Corp (GERN) (Director). Across all of them we count 2 purchases worth $112.4K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($30.4K) and 0 sales ($0). The largest single trade was a purchase of 40,000 shares of Crescent Biopharma, INC. worth $82.0K, dated 2021-11-16. The first filing on our record is dated 2021-11-18 and the latest 2026-06-03.
Crescent Biopharma, INC. (GLYC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-16 | P, purchase reported on Form 4 | 40,000 | $82.0K | 2021-11-18 |
Oncolytics Biotech INC (ONCY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-12 | P, purchase reported on Form 4 | 35,400 | $30.4K | 2026-02-13 |
Geron Corp (GERN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1445710) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms